Molecular Templates Inc (MTEM) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Molecular Templates Inc (MTI), formerly Threshold Pharmaceuticals Inc, is a clinical-stage oncology company that discovers and develops biologic therapeutics for cancer. The companys pipeline products include MT-3724, MT-4019, MT-5111, MT-5050 and MT-6868. Its lead product MT-3724, a fusion protein, is designed for the treatment of Non-Hodgkin Lymphoma; and MT-4019 is used for the treatment of multiple myeloma. The company also develops Engineered Toxin Bodies (ETBs) for the treatment of breast cancer, melanoma and allogeneic stem cell transplantation. The company develops ETBs for various targets including CD20, CD38, HER2, and PD-L1. MTI is headquartered in Austin, Texas, the US.

Molecular Templates Inc (MTEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Molecular Templates Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Molecular Templates Raises USD40 million in Venture Financing 10
Molecular Templates Raises Additional USD3.5 Million in Series C Financing 12
Molecular Templates Raises USD7 Million in Venture Financing 13
Molecular Templates Raises US$8.5 Million In Series C Financing 14
Partnerships 15
AbCheck and Molecular Templates Enter into Agreement 15
Takeda Pharma Enters into Research Agreement with Molecular Templates 16
Molecular Templates Enters into Research Agreement with MD Anderson Cancer Center 17
Molecular Templates Enters into Agreement with Veristat 18
Merger 19
Molecular Templates Merges with Threshold Pharma 19
Equity Offering 21
Molecular Templates Files Registration Statement to Raise Funds through Public Offering of Shares 21
Molecular Templates Raises USD20 million in Equity Financing 22
Acquisition 23
Threshold Pharma Acquires Molecular Templates 23
Molecular Templates Inc - Key Competitors 25
Molecular Templates Inc - Key Employees 26
Molecular Templates Inc - Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
Financial Announcements 28
Aug 09, 2018: Molecular Templates reports second quarter 2018 financial results 28
May 14, 2018: Molecular Templates Announces First Quarter 2018 Financial Results 30
Mar 28, 2018: Molecular Templates Announces Fourth Quarter 2017 Financial Results 31
Nov 14, 2017: Molecular Templates Reports Third Quarter 2017 Financial Results 33
Corporate Communications 35
Nov 14, 2017: Molecular Templates Strengthens Management Team with Appointment of Adam Cutler as Chief Financial Officer 35
Clinical Trials 37
Jun 13, 2017: Threshold Pharmaceuticals Announces First Patient Dosed in Immunotherapy Clinical Trial of Evofosfamide and Ipilimumab 37
Mar 30, 2017: Molecular Templates Announces Presentation on MT-4019 at the 2017 American Association for Cancer Research Annual Meeting 38
Other Significant Developments 39
Jan 05, 2018: Molecular Templates Provides Corporate Update and Outlines 2018 Milestones 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List Of Tables


Molecular Templates Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Molecular Templates Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Molecular Templates Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Molecular Templates Raises USD40 million in Venture Financing 10
Molecular Templates Raises Additional USD3.5 Million in Series C Financing 12
Molecular Templates Raises USD7 Million in Venture Financing 13
Molecular Templates Raises US$8.5 Million In Series C Financing 14
AbCheck and Molecular Templates Enter into Agreement 15
Takeda Pharma Enters into Research Agreement with Molecular Templates 16
Molecular Templates Enters into Research Agreement with MD Anderson Cancer Center 17
Molecular Templates Enters into Agreement with Veristat 18
Molecular Templates Merges with Threshold Pharma 19
Molecular Templates Files Registration Statement to Raise Funds through Public Offering of Shares 21
Molecular Templates Raises USD20 million in Equity Financing 22
Threshold Pharma Acquires Molecular Templates 23
Molecular Templates Inc, Key Competitors 25
Molecular Templates Inc, Key Employees 26

List Of Figures


Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Molecular Templates Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Integral Molecular Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Integral Molecular Inc (Integral Molecular) is a biotechnology company that provides therapeutic solutions. The company offers technologies and therapeutic antibodies for under exploited membrane protein targets. It provides lipoparticle, shotgun

USD 250 View Report

Molecular Templates Inc (MTEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Molecular Templates Inc (MTI), formerly Threshold Pharmaceuticals Inc, is a clinical-stage oncology company that discovers and develops biologic therapeutics for cancer. The companys pipeline products include MT-3724, MT-4019, MT-5111, MT-5050

USD 250 View Report

Molecular Templates Inc (MTEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Molecular Templates Inc (MTI), formerly Threshold Pharmaceuticals Inc, is a clinical-stage oncology company that discovers and develops biologic therapeutics for cancer. The companys pipeline products include MT-3724, MT-4019, MT-5111, MT-5050

USD 250 View Report

Molecular Templates Inc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Molecular Templates Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Molecular Templates Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description,

USD 350 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available